4//SEC Filing
SMISEK JEFFERY A 4
Accession 0001209191-21-023075
CIK 0001733257other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 6:08 PM ET
Size
21.4 KB
Accession
0001209191-21-023075
Insider Transaction Report
Form 4
SMISEK JEFFERY A
Director
Transactions
- Conversion
Common Stock
2021-03-23+272,245→ 1,606,306 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2021-03-23−141,928→ 0 total(indirect: See footnote)→ Common Stock (141,928 underlying) - Conversion
Series D Preferred Stock
2021-03-23−272,245→ 0 total(indirect: See footnote)→ Common Stock (272,245 underlying) - Conversion
Common Stock
2021-03-23+894,955→ 894,955 total(indirect: See footnote) - Conversion
Common Stock
2021-03-23+297,178→ 1,334,061 total(indirect: See footnote) - Conversion
Common Stock
2021-03-23+141,928→ 1,036,883 total(indirect: See footnote) - Purchase
Common Stock
2021-03-23$17.00/sh+88,235$1,499,995→ 1,694,541 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2021-03-23−894,955→ 0 total(indirect: See footnote)→ Common Stock (894,955 underlying) - Conversion
Series C Preferred Stock
2021-03-23−297,178→ 0 total(indirect: See footnote)→ Common Stock (297,178 underlying)
Footnotes (2)
- [F1]Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
- [F2]The securities are held by Flight Partners Management LLC ("Flight Partners Capital"). The Reporting Person is the president of Flight Partners Capital.
Documents
Issuer
Finch Therapeutics Group, Inc.
CIK 0001733257
Entity typeother
Related Parties
1- filerCIK 0001193038
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 6:08 PM ET
- Size
- 21.4 KB